These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 17895

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The pharmacokinetics of procainamide in normal subjects using a specific gas chromatographic assay.
    Simons KJ, Levy RH, Cutler RE, Christopher GT, Lindner A.
    Res Commun Chem Pathol Pharmacol; 1975 Jun; 11(2):173-85. PubMed ID: 1153866
    [Abstract] [Full Text] [Related]

  • 23. Longer plasma half-life for procainamide utilizing a very sensitive high performance liquid chromatography assay.
    Jamali F, Alballa RS, Mehvar R, Lemko CH.
    Ther Drug Monit; 1988 Jun; 10(1):91-6. PubMed ID: 2453956
    [Abstract] [Full Text] [Related]

  • 24. [Pharmacokinetics of procainamide and its metabolite depending on acetylator phenotype].
    Gawrońska-Szklarz B, Górnik W, Kutrzeba J, Wójcicki J, Zakrzewski J.
    Pol Tyg Lek; 1988 Jun; 47(40-41):921-3. PubMed ID: 1284448
    [Abstract] [Full Text] [Related]

  • 25. [Simultaneous predictions of disposition kinetics of procainamide and its metabolite N-acetylprocainamide in rat by a physiological pharmacokinetic model].
    Liu XD, Deng N, Huang SK.
    Yao Xue Xue Bao; 1991 Jun; 26(10):725-32. PubMed ID: 1726674
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics of N-acetylprocainamide.
    Atkinson AJ, Ruo TI.
    Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
    [Abstract] [Full Text] [Related]

  • 28. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
    Funck-Brentano C, Light RT, Lineberry MD, Wright GM, Roden DM, Woosley RL.
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Identification of desethyl procainamide in patients: a new metabolite of procainamide.
    Ruo TI, Morita Y, Atkinson AJ, Henthorn T, Thenot JP.
    J Pharmacol Exp Ther; 1981 Feb; 216(2):357-62. PubMed ID: 6162026
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. More-sensitive enzyme-multiplied immunoassay technique for procainamide and N-acetylprocainamide in plasma, serum, and urine.
    Henry PR, Dhruv RA.
    Clin Chem; 1988 May; 34(5):957-60. PubMed ID: 2453309
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of N-acetylation of procainamide and renal clearance of N-acetylprocainamide by para-aminobenzoic acid in humans.
    Tisdale JE, Rudis MI, Padhi ID, Svensson CK, Webb CR, Borzak S, Ware JA, Krepostman A, Zarowitz BJ.
    J Clin Pharmacol; 1995 Sep; 35(9):902-10. PubMed ID: 8786250
    [Abstract] [Full Text] [Related]

  • 39. [Combined pharmacokinetic and pharmacodynamic model analysis for procainamide and its metabolite].
    Liu XQ, Huang SK.
    Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):7-11. PubMed ID: 1719744
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.